Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Salloum, Ihsan M
NCT02582905: Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders	Completed	4	96	US	Placebo, Sugar pill, Citicoline, CDP-Choline, cytidine diphosphate-choline, Pregnenolone, pregn-5-en-3β-ol-20-one	Sherwood Brown, MD, PhD, University of Miami, University of Texas Rio Grande Valley	Alcohol Use Disorder, Bipolar Disorder, Schizoaffective Disorder Bipolar Type	05/23	05/23
ALAUNUS, NCT03265808: Allogeneic Human Mesenchymal Stem Cell Infusion Vs Placebo in Alcohol Use Disorder and Major Depression.	Active, not recruiting	1/2	80	US	allogeneic human mesenchymal stem cells (allo-hMSCs), Placebo	Ihsan M Salloum, MD, MPH, National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Major Depressive Disorder, Alcohol Use Disorder	07/25	07/25
John, Vineeth
No trials found